PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study data.

Sue Ellen Cox,Benjamin Ascher,Rui L Avelar,Kenneth R Beer,Jean Carruthers,Hugues Cartier,Steven Fagien,Nowell Solish

Journal of cosmetic dermatology（2023）

引用 0|浏览7

暂无评分

摘要

20 U prabotulinumtoxinA administered for the treatment of glabellar lines was efficacious in patients 65 years of age and older; it was also well tolerated by this cohort.

查看译文

关键词

botulinum toxin type A,glabellar lines,patients ≥65 years,prabotulinumtoxinA

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要